- Platinum Innovator Stamp - CV6 Therapeutics

Menu

About Us
Science
Pipeline
Partnerships
News
Contact Us

Uncategorised

Recent Posts

CV6 Announces Initiation of Patient Dosing in CV6-168 Phase 1a Clinical Trial
CV6 to Present Details of Ongoing Phase 1a Clinical Trial at 2024 ASCO Annual Meeting
CV6 Therapeutics to Attend JP Morgan Week
CV6 Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial
CV6 CEO Co-authors Study on Cancer Care in Ireland

– Platinum Innovator Stamp

13th January 2021

© 2025 CV6 Therapeutics (NI) Ltd. All rights reserved.

Website by Pale Blue Dot

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.